GSK 366, Purity ≥98%

Synonym: 1953157-39-5; GSK366; GSK-366; 3-[5-Chloro-6-[(1R)-1-(6-methylpyridazin-3-yl)ethoxy]-1,2-benzoxazol-3-yl]propanoic acid

CAS Number: 1953157-39-5
Compound CID: 121415048

Product Size

1 mg; 5 mg; 10 mg; 20 mg

Price

Datasheet

MSDS

Properties

Description

GSK 366 is a potent kynurenine-3-monooxygenase (KMO) inhibitor. The molecular weight of the compound is 361.78, and its molecular formula is C₁₇H₁₆ClN₃O₄.

Molecular Weight

361.78

Molecular Formula

C₁₇H₁₆ClN₃O₄

Form

Lyophilized powder

Purity

Impurities

Free from inappropriate visible particulates, foreign matter, discoloration, or other defects.

Identity

Confirmed by NMR/HPLC/MS.

Applications

GSK 366 plays a key role in promoting apoptosis in cancer cells that are otherwise resistant to cell death.